ANN ARBOR, Mich.–(BUSINESS WIRE)–Sling Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye disease (TED), today announced the first patients have been dosed in the global Phase 3 ORBIT pivotal trial, a global, randomized, double-masked, placebo-controlled study evaluating the efficacy and safety of linsitinib, an oral small molecule inhibitor of the insulin-like growth factor-1 receptor (IGF-1R), in

SAN FRANCISCO–(BUSINESS WIRE)–Perpetuals.com Ltd. (NASDAQ: PDC) today announced that it has filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission, reporting financial results for the fiscal year ended April 30, 2026. Total assets reached $65.2 million as of April 30, 2026, up more than 50-fold from the prior year, reflecting the company’s transformation to a fintech company that pairs proprietary AI with regulated market infrastructure to open global markets to

ST. LOUIS–(BUSINESS WIRE)– #ConstructionERP–SelectView, a trusted construction technology partner specializing in purpose-built solutions that help Trimble Viewpoint Vista and Spectrum users turn complex ERP data into actionable business insights including reporting, and dashboard solutions, announced today that Janice Newland has joined the company as Director of Sales and Business Development. Her appointment was effective August 31, 2026. Newland will lead SelectView’s sales and business development efforts

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.